相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Kelli A. Lytle et al.
PLOS ONE (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis
Jef Verbeek et al.
GUT (2015)
Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis
Bibiana Rius et al.
FASEB JOURNAL (2014)
Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Patients With Hepatocellular Carcinoma in the U. S.
Robert J. Wong et al.
HEPATOLOGY (2014)
Nutraceuticals and dyslipidaemia: Beyond the common therapeutics
Pietro Scicchitano et al.
JOURNAL OF FUNCTIONAL FOODS (2014)
Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone
Hironori Nakagami et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
The Role of Lifestyle Change in the Prevention and Treatment of NAFLD
Elena Centis et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Paola Dongiovanni et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease
Elena Centis et al.
JOURNAL OF HEPATOLOGY (2013)
The role of angiotensin II in nonalcoholic steatohepatitis
E. Matthew Morris et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Pharmacological agents for NASH
Vlad Ratziu
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Dietary Modification Dampens Liver Inflammation and Fibrosis in Obesity-Related Fatty Liver Disease
Claire Z. Larter et al.
OBESITY (2013)
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
Takumi Hirata et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
Pierre Bedossa et al.
HEPATOLOGY (2012)
Phenotyping the effect of diet on non-alcoholic fatty liver disease
Nicole J. W. de Wit et al.
JOURNAL OF HEPATOLOGY (2012)
Anti-fibrotic therapy: Lost in translation?
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Christian Thoma et al.
JOURNAL OF HEPATOLOGY (2012)
Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Obesity and Gastrointestinal Hormones-Dual Effect of Angiotensin II Receptor Blockade and a Partial Agonist of PPAR-γ
Hironori Nakagami et al.
CURRENT VASCULAR PHARMACOLOGY (2011)
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
Michael R. Charlton et al.
GASTROENTEROLOGY (2011)
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Arun J. Sanyal et al.
HEPATOLOGY (2011)
Insufficient Activation of Autophagy Allows Cellular Damage to Accumulate in Critically Ill Patients
Ilse Vanhorebeek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data
Hannele Yki-Jarvinen
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?
Eugen Florin Georgescu
ADVANCES IN THERAPY (2008)
Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis
Patricio Ibanez et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE-/- mice
Maria E. Johansson et al.
JOURNAL OF HYPERTENSION (2006)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa et al.
HEPATOLOGY (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
分享论文
